What is Rituximab?

Category: Prescription Drugs

Most popular types: Rituxan Mabthera

false

See also: DRC protocol FCMR protocol ILD Phase II/III Rituximab Versus Cyclophosphamide RECITAL Study R-CVP protocol RT protocol

Rituximab is a medication in a class of medications called monoclonal antibodies and given by infusion. It is used in the treatment of non-Hodgkins lymphoma and also in the treatment of rheumatoid arthritis.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Multiple sclerosis 120 77
Rheumatoid arthritis 97 47
Neuromyelitis optica 61 36
Systemic lupus erythematosus 21 9
Chronic lymphocytic leukemia 18 9

Show all 83 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 33
Moderate 38
Mild 77
None 79

Commonly reported side effects and conditions associated with Rituximab

Side effect Patients Percentage
Fatigue 32
Nausea 22
Headaches 11
Hair loss 6
Tiredness 6
Decreased appetite 4

Show all 105 reported side effects

Dosages

Based on patients currently taking Rituximab

Dosage Patients Percentage
10 mg every 6 months 6
500 mg every 6 months 3
10 mg every 12 weeks 2
1000 mg every 3 months 2
1000 mg every other week 2
1000 mg every 6 months 2
2 g yearly 1
1 intl units every 3 months 1
10 mg every 3 months 1
10 mg every 6 weeks 1

See all 21 dosages

Why patients stopped taking Rituximab

Multiple reasons could be selected

Reason Patients Percentage
Course of treatment ended 57
Did not seem to work 38
Doctor's advice 30
Side effects too severe 26
Other 21
Change in health plan coverage 5
Expense 4
Personal research 3
See all 158 patients who've stopped taking Rituximab

Duration

Currently taking Rituximab

Duration Patients Percentage
1 - 6 months 1
6 months - 1 year 2
1 - 2 years 8
2 - 5 years 16
5 - 10 years 8
10 years or more 2

Stopped taking Rituximab

Duration Patients Percentage
Less than 1 month 64
1 - 6 months 31
6 months - 1 year 20
1 - 2 years 17
2 - 5 years 23
5 - 10 years 2
10 years or more 1
Adherence
Adherence Evaluations Percentage
Always 201
Usually 7
Sometimes 5
Never taken as prescribed 14
Burden
Burden Evaluations Percentage
Very hard to take 20
Somewhat hard to take 66
A little hard to take 72
Not at all hard to take 69
Cost per month
Cost per month Evaluations Percentage
$200+ 37
$100-199 12
$50-99 5
$25-49 4
< $25 64
Not specified 105

What people switch to and from

Patients started taking Rituximab after stopping:

Treatment Patients Percentage
Natalizumab (Tysabri) 17
Glatiramer acetate (Copaxone) 11
Dimethyl fumarate (Tecfidera) 8
Fingolimod (Gilenya) 8
Methotrexate (Trexall) 7

Show all 29 treatments patients report switching from

Patients stopped taking Rituximab and switched to:

Treatment Patients Percentage
Ocrelizumab (Ocrevus) 5
Tocilizumab (Actemra) 5
Natalizumab (Tysabri) 4
Dimethyl fumarate (Tecfidera) 2
Ibrutinib (Imbruvica) 2

Show all 22 treatments patients report switching to

Last updated:

18 patient evaluations for Rituximab

May 18, 2018 (Started Jan 15, 2016)

  • Effectiveness
    Slight (for follicular lymphoma)
  • Effectiveness
    Slight (for non-Hodgkin's lymphoma)
  • Side effects
    Mild (fatigue)
  • Adherence
    Never taken as prescribed
  • Burden
    Somewhat hard to take
Advice & Tips: Discontinued December 2016 because treatment was no longer having any effect on my lymphoma
Cost: < $25 monthly

Jan 29, 2017 (Started Jan 15, 2016)

  • Effectiveness
    Moderate (for follicular lymphoma)
  • Effectiveness
    Moderate (for non-Hodgkin's lymphoma)
  • Side effects
    Moderate (fatigue)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Cost: < $25 monthly

Dec 15, 2016 (Started Jan 15, 2016)

  • Effectiveness
    Slight (for follicular lymphoma)
  • Effectiveness
    Slight (for non-Hodgkin's lymphoma)
  • Side effects
    Moderate (fatigue)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 10 mg Weekly
Cost: < $25 monthly

  • 0 helpful marks

Feb 15, 2017 (Started Jul 15, 2016)

  • Effectiveness
    Moderate (for multiple sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: As needed

  • 1 helpful mark

Sep 24, 2016 (Started Sep 11, 2014)

  • Effectiveness
    Slight (for rheumatoid arthritis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: As needed
Advice & Tips: I had 2 infusions, 14 days apart. And that was it. The effect was not worth the price according to my rheumatologist (I paid nothing myself)
Cost: < $25 monthly

Jul 1, 2014 (Started Sep 11, 2014)

  • Effectiveness
    Slight (for rheumatoid arthritis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Cost: < $25 monthly

  • 0 helpful marks
Last updated:
Showing 3 of 18 patient evaluations for Rituximab